DAICEL CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,448 JPY | 0.00% |
|
+4.14% | +5.97% |
| Mar. 27 | Daicel Corp. Completes 15 Billion Yen Buyback Program | MT |
| Mar. 26 | Tranche Update on Daicel Corporation's Equity Buyback Plan announced on November 2, 2023. | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Its low valuation, with P/E ratio at 7.44 and 8.01 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company is in debt and has limited leeway for investment
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +5.97% | 2.54B | B+ | ||
| -25.15% | 20.6B | B- | ||
| -14.52% | 13.21B | B- | ||
| -8.75% | 9.69B | A- | ||
| -13.48% | 9.66B | B+ | ||
| -4.50% | 6.61B | C+ | ||
| +3.01% | 6.42B | C+ | ||
| -30.31% | 5.29B | C | ||
| -21.00% | 3.3B | A | ||
| -34.73% | 3.06B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 4202 Stock
- Ratings Daicel Corporation
